Insud Pharma
Pilar Calero Martínez has extensive experience in human resources and talent acquisition, currently serving as HRBP for the Chemo Business Unit at Insud Pharma since November 2018, where responsibilities include recruiting talent, managing manufacturing site structures, and coordinating a team of five. Previously, Pilar held the position of Talent Acquisition Leader, focusing on recruitment processes and talent projects for national and international locations. Pilar's prior experience includes roles as a Senior Recruiter and a Senior Engineering Consultant at Robert Walters, where recruitment for technical profiles in industrial sectors was a key responsibility. Pilar began developing expertise in engineering and project management as a Project Engineer at HUNTEC and has a solid educational background with a Bachelor's degree in Industrial Engineering and Electrical Engineering from Universitat Politècnica de València.
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.